You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 7,109,028


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,109,028
Title:Methods of isolating hepatic progenitors
Abstract: This invention relates to methods of isolating hepatoblasts utilizing panning techniques and fluorescence activated cell sorting. This invention further relates to isolated hepatoblasts and to a method of treating liver dysfunction as well as to methods of forming artificial livers.
Inventor(s): Reid; Lola M. (Chapel Hill, NC), Sigal; Samuel H. (Riverdale, NY), Brill; Shlomo (Ramat-Gan, IL), Holst; Patricia A. (Ossining, NY)
Assignee: Albert Einstein College of Medicine of Yeshiva University (Bronx, NY)
Application Number:09/873,286
Patent Claims:1. A method of enriching for hepatic progenitors from liver comprising: (a) preparing a single-cell suspension of liver cells; and (b) panning said suspension utilizing antibodies specific for hemopoietic cells, mesenchymal cells, or mature liver cells, or combinations thereof, to remove said hemopoietic cells, mesenchymal cells, or mature liver cells, or combinations thereof, from said suspension such that said suspension is enriched in hepatic progenitors; wherein the liver is adult liver.

2. The method of claim 1 wherein the mesenchymal cells comprise endothelial cells.

3. The of claim 1 wherein method the mature liver cells comprise at least one of hepatocytes and bile duct cells.

4. The method of claim 1 which further comprises performing multiparametric fluorescence activated cell sorting on said suspension utilizing at least one antibody to a hepatic cell marker, side scatter, forward scatter, autofluorescence, or combinations thereof.

5. The method of claim 1 wherein the antibodies specific for hemopoietic cells are monoclonal antibodies.

6. The method of claim 1 wherein said single cell suspension comprises an agent capable of removing calcium from liver cell surface.

7. The method of claim 1 wherein said single cell suspension comprises EGTA.

8. The method of claim 1 wherein said single cell suspension comprises an enzyme capable of dissociating liver cells.

9. The method of claim 1 wherein said single cell suspension contains collagenase.

10. The method of claim 1 wherein said single cell suspension is chilled.

11. The method of claim 1 wherein said single cell suspension is at a temperature of between about 2 and 20.degree. C.

12. The method of claim 5 wherein said monoclonal antibodies are at least one of OX-43 and OX-44.

13. The method of claim 1 said hepatic cell marker is OC.3.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.